Compassionate Use and Expanded Access in Rare Disease Therapies
Compassionate Use and Expanded Access in Rare Disease Therapies Ethical and Regulatory Perspectives on Compassionate Use in Rare Disease Treatment Understanding Compassionate Use and Expanded Access Programs For patients with rare and life-threatening diseases, conventional treatment options are often limited or nonexistent. When clinical trial participation is not feasible due to geographic, medical, or eligibility…
Read More “Compassionate Use and Expanded Access in Rare Disease Therapies” »